| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥5.21 |
| 52 Week High | CN¥6.93 |
| 52 Week Low | CN¥3.43 |
| Beta | 0.13 |
| 1 Month Change | 0.77% |
| 3 Month Change | 34.63% |
| 1 Year Change | -9.55% |
| 3 Year Change | -33.29% |
| 5 Year Change | 16.55% |
| Change since IPO | 77.51% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300318 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 9.0% | 3.4% | 1.2% |
| 1Y | -9.5% | -13.1% | -12.6% |
Return vs Industry: 300318 exceeded the CN Medical Equipment industry which returned -13.1% over the past year.
Return vs Market: 300318 exceeded the CN Market which returned -12.6% over the past year.
Price Volatility
| 300318 volatility | |
|---|---|
| 300318 Average Weekly Movement | 10.1% |
| Medical Equipment Industry Average Movement | 7.7% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 12.1% |
| 10% least volatile stocks in CN Market | 5.0% |
Stable Share Price: 300318's share price has been volatile over the past 3 months.
Volatility Over Time: 300318's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 1,773 | Zhiwei Shen | www.bohui-tech.com |
Beijing Bohui Innovation Biotechnology Group Co., Ltd. engages in the research and development, production, sale, and after-sale service of diagnostic products in China. It offers GenPlex, a microfluidic automated nucleic acid detection system, immunofluorescence detection products, and human trace element detection products; and chemical analysis products, such as atomic fluorescence; mass spectrometry and separation analysis, life sciences related consumables, and ICP spectroscopy.
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Fundamentals Summary
| 300318 fundamental statistics | |
|---|---|
| Market cap | CN¥4.26b |
| Earnings (TTM) | -CN¥10.24m |
| Revenue (TTM) | CN¥1.05b |
4.0x
P/S Ratio-415.6x
P/E RatioIs 300318 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300318 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.05b |
| Cost of Revenue | CN¥558.57m |
| Gross Profit | CN¥495.96m |
| Other Expenses | CN¥506.20m |
| Earnings | -CN¥10.24m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.013 |
| Gross Margin | 47.03% |
| Net Profit Margin | -0.97% |
| Debt/Equity Ratio | 38.1% |
How did 300318 perform over the long term?
See historical performance and comparison